Total Payments
$6,163
2024 Payments
$615.60
Companies
33
Transactions
375
Medicare Patients
4,249
Medicare Billing
$339,042
Payment Breakdown by Category
Food & Beverage$6,163 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,163 | 375 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,610 | 124 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $854.14 | 49 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $663.16 | 34 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $588.74 | 37 | $0 (2024) |
| Philips Electronics North America Corporation | $288.10 | 21 | $0 (2023) |
| GENZYME CORPORATION | $232.95 | 12 | $0 (2024) |
| Insmed, Inc. | $217.86 | 12 | $0 (2024) |
| PFIZER INC. | $167.32 | 9 | $0 (2021) |
| Mylan Specialty L.P. | $151.43 | 8 | $0 (2021) |
| Gilead Sciences, Inc. | $142.14 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $615.60 | 35 | GlaxoSmithKline, LLC. ($208.75) |
| 2023 | $805.81 | 47 | GlaxoSmithKline, LLC. ($295.28) |
| 2022 | $437.97 | 18 | United Therapeutics Corporation ($122.79) |
| 2021 | $724.75 | 39 | Boehringer Ingelheim Pharmaceuticals, Inc. ($144.04) |
| 2020 | $987.54 | 58 | Boehringer Ingelheim Pharmaceuticals, Inc. ($234.79) |
| 2019 | $871.57 | 56 | GlaxoSmithKline, LLC. ($221.73) |
| 2018 | $1,272 | 88 | GlaxoSmithKline, LLC. ($483.78) |
| 2017 | $447.56 | 34 | GlaxoSmithKline, LLC. ($166.44) |
All Payment Transactions
375 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Immunology | ||||||
| 09/25/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: NEUROLOGY | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: RESPIRATORY | ||||||
| 07/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Respiratory | ||||||
| 07/03/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 06/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Respiratory | ||||||
| 05/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: PULMONOLOGY | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 04/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: RESPIRATORY | ||||||
| 04/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 600 | 1,811 | $133,743 | $49,472 |
| 2022 | 21 | 1,041 | 3,082 | $218,961 | $80,366 |
| 2021 | 19 | 1,060 | 2,130 | $219,557 | $84,630 |
| 2020 | 29 | 1,548 | 3,755 | $353,441 | $124,573 |
Total Patients
4,249
Total Services
10,778
Medicare Billing
$339,042
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 154 | $36,561 | $13,341 | 36.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 23 | 885 | $25,396 | $9,734 | 38.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 90 | $13,555 | $5,534 | 40.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 32 | $10,872 | $4,316 | 39.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $5,558 | $2,153 | 38.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 45 | 45 | $5,171 | $1,825 | 35.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $4,534 | $1,819 | 40.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 47 | $4,093 | $1,810 | 44.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 46 | 46 | $5,125 | $1,767 | 34.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 21 | 21 | $3,035 | $1,315 | 43.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 17 | 17 | $2,745 | $1,206 | 43.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 22 | 124 | $2,816 | $978.88 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $2,217 | $944.14 | 42.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 58 | 59 | $4,882 | $934.70 | 19.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 38 | 38 | $2,486 | $719.06 | 28.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 55 | $1,914 | $575.07 | 30.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 12 | 12 | $1,129 | $321.75 | 28.5% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 14 | 15 | $533.72 | $166.01 | 31.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 112 | $1,120 | $10.88 | 1.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 168 | $35,671 | $16,240 | 45.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 167 | 296 | $40,347 | $16,181 | 40.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 52 | 52 | $19,198 | $7,924 | 41.3% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 21 | 600 | $18,156 | $6,406 | 35.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 63 | $12,316 | $4,956 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 61 | 61 | $11,468 | $4,786 | 41.7% |
About Dr. Qamar Arfeen, M.D
Dr. Qamar Arfeen, M.D is a Allergy & Immunology healthcare provider based in Beaumont, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295738649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Qamar Arfeen, M.D has received a total of $6,163 in payments from pharmaceutical and medical device companies, with $615.60 received in 2024. These payments were reported across 375 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,163).
As a Medicare-enrolled provider, Arfeen has provided services to 4,249 Medicare beneficiaries, totaling 10,778 services with total Medicare billing of $339,042. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Critical Care Medicine, General Practice
- Location Beaumont, TX
- Active Since 05/31/2005
- Last Updated 11/11/2024
- Taxonomy Code 207RA0201X
- Entity Type Individual
- NPI Number 1295738649
Products in Payments
- TRELEGY ELLIPTA (Drug) $909.38
- UPTRAVI (Drug) $547.55
- OFEV (Drug) $430.67
- STIOLTO RESPIMAT (Drug) $370.44
- ANORO (Drug) $234.62
- Arikayce (Drug) $217.86
- DUPIXENT (Biological) $212.69
- BEVESPI AEROSPHERE (Drug) $189.55
- BREO (Drug) $174.40
- ELIQUIS (Drug) $167.32
- TEZSPIRE (Biological) $152.13
- Yupelri (Drug) $139.81
- AREXVY (Drug) $137.49
- (8874) inCourage (Device) $123.59
- TYVASO (Drug) $122.79
- NUCALA (Biological) $117.36
- Xolair (Biological) $111.65
- COOK MEDICAL ENDOSCOPIC ULTRASOUND (Device) $105.74
- FASENRA (Drug) $104.72
- BREZTRI (Drug) $99.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.